RVL Pharmaceuticals PLC expected to post a loss of 12 cents a share - Earnings Preview

RVL Pharmaceuticals

09/05/2023 16:10

* RVL Pharmaceuticals PLC  RVLP.OQ   RVLP.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 11. 
    * The Bridgewater New Jersey-based  company is expected to
report 
a 56.0% decrease in revenue to $9.441 million from $21.44
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for RVL Pharmaceuticals
PLC
is for a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for RVL
Pharmaceuticals PLC is $3​, above​ its last closing price
of $0.77. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.15       -0.16      -0.18     Missed  -12.7
 Sep. 30 2022  -0.15       -0.16      -0.16     Met     -0.5
 Jun. 30 2022  -0.20       -0.21      -0.14     Beat    32.5​
 Mar. 31 2022  -0.16       -0.17      -0.25     Missed  -45.6
 ​​Dec.        -0.25       -0.27      -0.30     Missed  -12.5
 31 2021                                                
 Sep. 30 2021  -0.31       -0.31      -0.28     Beat    11.1​
 Jun. 30 2021  -0.14       -0.14      -0.28     Missed  -100
 Mar. 31 2021  -0.23       -0.23      -0.15     Beat    36.2
 This summary was machine generated May 9 at 15:10 GMT.  All
figures in US dollars  unless otherwise stated